3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
3
Study Type
Interventional
91
Observational
3
Sponsor
Cancer Type
Gastrointestinal
3
Conditions
Pancreatic Neoplasms
6
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
3
Biliary Tract Neoplasms
3
Neoplasms
2
Stomach Neoplasms
1
Pancreatic Cancer Resectable
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Locally Advanced Pancreatic Adenocarcinoma
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Breast Cancer Organoids
1
Brain Neoplasms
1
Interventions
Liquid Biopsy
4
Blood Specimen Collection
4
Gemcitabine
3
pembrolizumab
2
Immunohistochemistry
2
Cisplatin
2
Capecitabine
2
Base Sequence
2
130-nm albumin-bound paclitaxel
2
tislelizumab
1
taxane
1
lenvatinib
1
irinotecan sucrosofate
1
gemcitabine-oxaliplatin regimen
1
Tegafur
1
Taxes
1
Surgical Procedures, Operative
1
Standard of Care
1
S 1 (combination)
1
Polymerase Chain Reaction
1
Platinum Compounds
1
Oxaliplatin
1
Nivolumab
1
Microscopy, Confocal
1
Methylation
1
Mass Spectrometry
1
Leucovorin
1
Irinotecan
1
Immune Checkpoint Inhibitors
1
High-Throughput Nucleotide Sequencing
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Observational
×
Biliary Tract Neoplasms
×
Gemcitabine
×
Clear all
NCT06893380
2025-09-15
GENTIS
CHA University
Recruiting
61 enrolled
NCT06975917
2025-05-16
TOG-SAFRADJU
Ankara University
Active not recruiting
600 enrolled
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled